| scholarly article | Q13442814 |
| P2093 | author name string | A. E. Schivell | |
| R. H. Batchelor | |||
| S. M. Bajjalieh | |||
| P2860 | cites work | Ca(2+)-dependent and -independent activities of neural and non-neural synaptotagmins | Q24323300 |
| Brain contains two forms of synaptic vesicle protein 2 | Q24563310 | ||
| Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation | Q24681205 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Structure of the first C2 domain of synaptotagmin I: A novel Ca2+/phospholipid-binding fold | Q27729921 | ||
| The ABC of channel regulation | Q28297235 | ||
| SV2, a brain synaptic vesicle protein homologous to bacterial transporters | Q28566808 | ||
| Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse | Q28587672 | ||
| The synaptic vesicle cycle: a cascade of protein-protein interactions | Q29620168 | ||
| New vectors for high level expression of recombinant proteins in bacteria. | Q30341857 | ||
| Differential expression of the p65 gene family | Q33602421 | ||
| Evidence for synaptotagmin as an inhibitory clamp on synaptic vesicle release in Aplysia neurons | Q33772698 | ||
| Synaptotagmin I is a high affinity receptor for clathrin AP-2: implications for membrane recycling | Q34334008 | ||
| Tracing the roots of ion channels | Q35319776 | ||
| Solubilization of proteins from bovine brain coated vesicles by protein perturbants and Triton X-100 | Q36212452 | ||
| Synaptic vesicle membrane proteins interact to form a multimeric complex | Q36530918 | ||
| Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells. | Q41483110 | ||
| The synaptic vesicle protein SV2 is a novel type of transmembrane transporter | Q41603796 | ||
| Identification, characterization, and molecular cloning of a novel transporter-like protein localized to the central nervous system | Q42604680 | ||
| Synaptic function is impaired but not eliminated in C. elegans mutants lacking synaptotagmin | Q43328836 | ||
| Identification of synaptophysin as a hexameric channel protein of the synaptic vesicle membrane | Q44802556 | ||
| Vesicular transporters join the major facilitator superfamily (MFS) | Q47635344 | ||
| Interaction of synaptotagmin with the cytoplasmic domains of neurexins | Q48337903 | ||
| Regulation of hemicholinium-3 sensitive choline uptake in Xenopus laevis oocytes by the second C2 domain of synaptotagmin | Q49045832 | ||
| Distinct Ca(2+)-dependent properties of the first and second C2-domains of synaptotagmin I. | Q49161795 | ||
| A possible docking and fusion particle for synaptic transmission | Q59068229 | ||
| Inhibition of neurotransmitter release by C2-domain peptides implicates synaptotagmin in exocytosis | Q59072845 | ||
| P433 | issue | 44 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 27770–27775 | |
| P577 | publication date | 1996-11-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Isoform-specific, calcium-regulated interaction of the synaptic vesicle proteins SV2 and synaptotagmin | |
| P478 | volume | 271 |
| Q33944046 | A conserved mechanism of synaptogyrin localization |
| Q35217702 | A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam |
| Q24655420 | Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A) |
| Q37316102 | Association of botulinum neurotoxins with synaptic vesicle protein complexes |
| Q33869062 | Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors |
| Q33793263 | Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins |
| Q48071615 | Brivaracetam augments short-term depression and slows vesicle recycling |
| Q41541440 | Ca2+ and the regulation of neurotransmitter secretion |
| Q37034295 | Characterization of fetal and postnatal enteric neuronal cell lines with improvement in intestinal neural function |
| Q37179618 | Correlation of non-uniform protein expression with variation in transmitter release probability |
| Q33835261 | Cotrafficking of SV2 and synaptotagmin at the synapse. |
| Q28577061 | Delineation of the oligomerization, AP-2 binding, and synprint binding region of the C2B domain of synaptotagmin |
| Q52691207 | Developmental analysis of SV2 in the embryonic chicken corneal epithelium. |
| Q53082614 | Discovery of heterocyclic nonacetamide synaptic vesicle protein 2A (SV2A) ligands with single-digit nanomolar potency: opening avenues towards the first SV2A positron emission tomography (PET) ligands. |
| Q43205870 | Discovery of indolone acetamides as novel SV2A ligands with improved potency toward seizure suppression |
| Q52164560 | Drosophila AD3 mutation of synaptotagmin impairs calcium-dependent self-oligomerization activity. |
| Q30543846 | Early development of the gonadotropin-releasing hormone neuronal network in transgenic zebrafish |
| Q34927836 | Expression of SV2 isoforms during rodent brain development |
| Q38297276 | Formation of crystalloid endoplasmic reticulum induced by expression of synaptotagmin lacking the conserved WHXL motif in the C terminus. Structural importance of the WHXL motif in the C2B domain |
| Q74506578 | Functional analysis of the C2A domain of synaptotagmin 1: implications for calcium-regulated secretion |
| Q27655649 | Glycosylated SV2 and Gangliosides as Dual Receptors for Botulinum Neurotoxin Serotype F |
| Q33950706 | How does calcium trigger neurotransmitter release? |
| Q35357221 | Identification of the antiepileptic racetam binding site in the synaptic vesicle protein 2A by molecular dynamics and docking simulations |
| Q31064708 | Identification of two cDNAs encoding synaptic vesicle protein 2 (SV2)-like proteins from epithelial tissues in the cat flea, Ctenocephalides felis. |
| Q41222236 | Integration of Synaptic Vesicle Cargo Retrieval with Endocytosis at Central Nerve Terminals. |
| Q36773187 | Interaction of the synprint site of N-type Ca2+ channels with the C2B domain of synaptotagmin I. |
| Q30479251 | Interaural timing difference circuits in the auditory brainstem of the emu (Dromaius novaehollandiae). |
| Q34004841 | Kisspeptins modulate the biology of multiple populations of gonadotropin-releasing hormone neurons during embryogenesis and adulthood in zebrafish (Danio rerio). |
| Q28478633 | Levetiracetam reverses synaptic deficits produced by overexpression of SV2A |
| Q46690409 | Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs |
| Q34872576 | Loss of the SV2-like protein SVOP produces no apparent deficits in laboratory mice |
| Q33432742 | Loss of the Synaptic Vesicle Protein SV2B results in reduced neurotransmission and altered synaptic vesicle protein expression in the retina. |
| Q30435547 | Modulation of the conformational state of the SV2A protein by an allosteric mechanism as evidenced by ligand binding assays |
| Q47833303 | Molecular Signatures Underlying Synaptic Vesicle Cargo Retrieval |
| Q34228641 | Molecular mechanisms of neurotransmitter release |
| Q35740426 | Overlapping functions of stonin 2 and SV2 in sorting of the calcium sensor synaptotagmin 1 to synaptic vesicles |
| Q35069723 | Phosphorylation of synaptic vesicle protein 2A at Thr84 by casein kinase 1 family kinases controls the specific retrieval of synaptotagmin-1. |
| Q42123208 | Phosphorylation-dependent interaction of the synaptic vesicle proteins cysteine string protein and synaptotagmin I. |
| Q52093729 | Presynaptic congenital myasthenic syndrome with a homozygous sequence variant in LAMA5 combines myopia, facial tics, and failure of neuromuscular transmission. |
| Q34807735 | Protein quantification at the single vesicle level reveals that a subset of synaptic vesicle proteins are trafficked with high precision |
| Q33598960 | Protein-protein interactions and protein modules in the control of neurotransmitter release |
| Q33710870 | Puzzling Out Synaptic Vesicle 2 Family Members Functions. |
| Q39847326 | Ras mutation impairs epithelial barrier function to a wide range of nonelectrolytes. |
| Q36827908 | Role of DHA in aging-related changes in mouse brain synaptic plasma membrane proteome |
| Q34669186 | Role of synaptotagmin in Ca2+-triggered exocytosis |
| Q58191267 | SV2 |
| Q34034957 | SV2 acts via presynaptic calcium to regulate neurotransmitter release. |
| Q47205051 | SV2 modulates the size of the readily releasable pool of secretory vesicles |
| Q26269919 | SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis |
| Q28512897 | SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release |
| Q28585094 | SV2B regulates synaptotagmin 1 by direct interaction |
| Q47894520 | SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family |
| Q33434528 | SVOP is a nucleotide binding protein |
| Q43266355 | Safeguards of Neurotransmission: Endocytic Adaptors as Regulators of Synaptic Vesicle Composition and Function |
| Q46629490 | Separation of antiepileptogenic and antiseizure effects of levetiracetam in the spontaneously epileptic rat (SER). |
| Q28138487 | Specificity of Ca2+-dependent protein interactions mediated by the C2A domains of synaptotagmins |
| Q94454332 | Synaptic dysfunction induced by glycine-alanine dipeptides in C9orf72-ALS/FTD is rescued by SV2 replenishment |
| Q33680888 | Synaptic vesicle docking and fusion |
| Q41718355 | Synaptic vesicle glycoprotein 2A modulates vesicular release and calcium channel function at peripheral sympathetic synapses |
| Q28293712 | Synaptic vesicle protein 2 enhances release probability at quiescent synapses |
| Q42286137 | Synaptic vesicle protein 2, A new neuroendocrine cell marker |
| Q38150436 | Synaptic vesicle protein 2A: basic facts and role in synaptic function |
| Q48027351 | Synaptotagmin I stabilizes synaptic vesicles via its C(2)A polylysine motif. |
| Q40867065 | Synaptotagmin regulation of coated pit assembly |
| Q51148309 | Synaptotagmin-2, and -1, linked to neurotransmission impairment and vulnerability in Spinal Muscular Atrophy. |
| Q48871184 | The C2A domain of double C2 protein gamma contains a functional nuclear localization signal |
| Q48881116 | The C2B domain of synaptotagmin I is a Ca2+-binding module |
| Q36328687 | The C2B domain of synaptotagmin is a Ca(2+)-sensing module essential for exocytosis |
| Q26768190 | The iTRAPs: Guardians of Synaptic Vesicle Cargo Retrieval During Endocytosis |
| Q37218057 | The neuromuscular junction |
| Q24297813 | The synaptic vesicle cycle |
| Q28141654 | The synaptic vesicle protein SV2 is complexed with an alpha5-containing laminin on the nerve terminal surface |
| Q24561949 | The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam |
| Q36294041 | The tandem C2 domains of synaptotagmin contain redundant Ca2+ binding sites that cooperate to engage t-SNAREs and trigger exocytosis. |
| Q33913247 | The tractable contribution of synapses and their component molecules to individual differences in learning |
| Q38261675 | Therapeutic target for nephrotic syndrome: Identification of novel slit diaphragm associated molecules |
| Q27637071 | Three-dimensional structure of the synaptotagmin 1 C2B-domain: synaptotagmin 1 as a phospholipid binding machine |
| Q30494084 | Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease |
Search more.